-
Je něco špatně v tomto záznamu ?
Jakými důkazy je podložena cílová hodnota krevního tlaku u chronického onemocnění ledvin?
[Blood pressure goal in chronic kidney disease: what is the evidence?]
Rajiv Agarwal
Jazyk čeština Země Česko
Typ dokumentu přehledy
- MeSH
- černoši nebo Afroameričané MeSH
- chronická nemoc MeSH
- hodnoty glomerulární filtrace MeSH
- hypertenze farmakoterapie MeSH
- krevní tlak MeSH
- lidé MeSH
- nemoci ledvin patofyziologie MeSH
- randomizované kontrolované studie jako téma MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- přehledy MeSH
Most guidelines recommend that seated clinic blood pressure (BP) be targeted to less than 130/80 mmHg in patients with chronic kidney disease (CKD). The evidence underlying these recommendations is the subject of this review. RECENT FINDINGS: The best evidence to target a certain level of BP in patients with CKD comes from randomized trials. Only three trials have prospectively examined the level to which BP should be lowered. These trials conducted exclusively among patients with CKD have demonstrated that compared to a less aggressive BP goal, a BP goal of less than 130/80 mmHg neither saves lives nor protects the kidney or the cardiovascular system. SUMMARY: It is reasonable to achieve a goal of less than 140/90 mmHg in most patients with CKD. More aggressive lowering is not firmly supported by current data. Since BP control is important, hypertension therapy should be individualized. Individualization through home BP measurements to diagnose, monitor and treat hypertension appears to be an attractive option.
Blood pressure goal in chronic kidney disease: what is the evidence?
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12000975
- 003
- CZ-PrNML
- 005
- 20120118095853.0
- 007
- ta
- 008
- 120118s2011 xr f 000 0cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Agarwal, Rajiv $u Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA $7 gn_A_00002095
- 245 10
- $a Jakými důkazy je podložena cílová hodnota krevního tlaku u chronického onemocnění ledvin? / $c Rajiv Agarwal
- 246 31
- $a Blood pressure goal in chronic kidney disease: what is the evidence?
- 504 __
- $a Literatura $b 14
- 520 9_
- $a Most guidelines recommend that seated clinic blood pressure (BP) be targeted to less than 130/80 mmHg in patients with chronic kidney disease (CKD). The evidence underlying these recommendations is the subject of this review. RECENT FINDINGS: The best evidence to target a certain level of BP in patients with CKD comes from randomized trials. Only three trials have prospectively examined the level to which BP should be lowered. These trials conducted exclusively among patients with CKD have demonstrated that compared to a less aggressive BP goal, a BP goal of less than 130/80 mmHg neither saves lives nor protects the kidney or the cardiovascular system. SUMMARY: It is reasonable to achieve a goal of less than 140/90 mmHg in most patients with CKD. More aggressive lowering is not firmly supported by current data. Since BP control is important, hypertension therapy should be individualized. Individualization through home BP measurements to diagnose, monitor and treat hypertension appears to be an attractive option.
- 650 _2
- $a černoši nebo Afroameričané $7 D001741
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x farmakoterapie $7 D006973
- 650 _2
- $a nemoci ledvin $x patofyziologie $7 D007674
- 650 _2
- $a randomizované kontrolované studie jako téma $7 D016032
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $t Current opinion in nephrology and hypertension $x 1802-3827 $g Roč. 5, č. 3 (2011), s. 70-73 $w MED00156014
- 910 __
- $a ABA008 $b B 2490 $c 903 $y 2
- 990 __
- $a 20120118084113 $b ABA008
- 991 __
- $a 20120118095840 $b ABA008
- 999 __
- $a ok $b bmc $g 893688 $s 757673
- BAS __
- $a 3
- BMC __
- $a 2011 $b 5 $c 3 $d 70-73 $i 1802-3827 $m Current Opinion in Nephrology and Hypertension (České vyd.) $n Curr. Opin. Nephrol. Hypertens. (Čes. vyd.) $x MED00156014
- LZP __
- $a 2012-02/mkme